180 related articles for article (PubMed ID: 35191627)
1. PGNMID and anti-CD38 monoclonal antibody: a therapeutic challenge.
Rahbari E; Barreca A; Nicolino B; Ciochetto C; Piraina V; Maroni S; Deagostini MC; Patti R; Bertucci P; Savoldi S
G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191627
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
[TBL] [Abstract][Full Text] [Related]
3. A case of proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) that responded favorably to steroid therapy.
Ogura Y; Yabushita S; Aihara H; Tsukada H; Hashiba T; Furuse S; Fujii A; Ueda Y; Mise N
CEN Case Rep; 2022 May; 11(2):208-215. PubMed ID: 34628583
[TBL] [Abstract][Full Text] [Related]
4. Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? : Two case reports and literature review.
van Kruijsdijk RCM; Abrahams AC; Nguyen TQ; Minnema MC; Jacobs JFM; Limper M
J Nephrol; 2020 Jun; 33(3):611-617. PubMed ID: 32221859
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits.
Zand L; Rajkumar SV; Leung N; Sethi S; El Ters M; Fervenza FC
J Am Soc Nephrol; 2021 May; 32(5):1163-1173. PubMed ID: 33685975
[TBL] [Abstract][Full Text] [Related]
6. Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.
Oki R; Unagami K; Taneda S; Takagi T; Ishida H
J Nephrol; 2022 May; 35(4):1289-1293. PubMed ID: 35522429
[TBL] [Abstract][Full Text] [Related]
7. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone.
Nasr SH; Larsen CP; Sirac C; Theis JD; Domenger C; Chauvet S; Javaugue V; Hogan JJ; Said SM; Dasari S; Vrana JA; McPhail ED; Cornell LD; Vilaine E; Massy ZA; Boffa JJ; Buob D; Toussaint S; Guincestre T; Touchard G; D'Agati VD; Leung N; Bridoux F
Kidney Int; 2020 Mar; 97(3):589-601. PubMed ID: 32001067
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide for the Treatment of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition.
Asif S; Mahmood SN; Mukhtar KN
Saudi J Kidney Dis Transpl; 2021; 32(4):1166-1170. PubMed ID: 35229819
[TBL] [Abstract][Full Text] [Related]
9. A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report.
Ito D; Shiozaki Y; Shimizu Y; Suzuki Y; Takeda A; Misaki T
BMC Nephrol; 2022 Dec; 23(1):396. PubMed ID: 36494791
[TBL] [Abstract][Full Text] [Related]
10. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
Bridoux F; Javaugue V; Nasr SH; Leung N
Nephrol Dial Transplant; 2021 Jan; 36(2):208-215. PubMed ID: 33494099
[TBL] [Abstract][Full Text] [Related]
11. A Review on the Diagnosis and Treatment of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits.
Lin L; Chen N
Int J Gen Med; 2022; 15():8577-8582. PubMed ID: 36540764
[TBL] [Abstract][Full Text] [Related]
12. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits triggered by COVID-19: a case report.
Shieh M; Giannini JA; Combs SA; Shaffi SK; Messias NC; Teixeira JP
CEN Case Rep; 2022 Aug; 11(3):380-385. PubMed ID: 35122206
[TBL] [Abstract][Full Text] [Related]
13. Membranoproliferative glomerulonephritis with deposition of monoclonal IgG evolved from polyclonal IgG: a case report with two consecutive renal biopsies.
Yu XJ; Hu N; Wang SX; Zhou FD; Zhao MH
BMC Nephrol; 2019 Jul; 20(1):275. PubMed ID: 31331283
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAκ deposits: a pattern switch.
Li JP; Du YT; Guo C; Rao XR; Li S
J Nephrol; 2023 Nov; 36(8):2375-2380. PubMed ID: 36913081
[TBL] [Abstract][Full Text] [Related]
15. An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
Li M; Xu G
Clin Kidney J; 2022 Jun; 15(6):1041-1048. PubMed ID: 35664272
[TBL] [Abstract][Full Text] [Related]
16. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
Liu M; Yu X; Wang S; Qin A; Zhou F; Zhao M
J Nephrol; 2022 Dec; 35(9):2363-2372. PubMed ID: 35460458
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance.
Lee H; Duggan P; Neri P; Tay J; Jimenez-Zepeda VH
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019007. PubMed ID: 30671213
[TBL] [Abstract][Full Text] [Related]
18. A tale of monoclonal immunoglobulin: Clinicopathological analysis of proliferative glomerulonephritis with monoclonal immunoglobulin deposit.
Maity P; Dasgupta S; Basu K; Sengupta M; Chowdhury AR; Bandopadhyay M
Indian J Pathol Microbiol; 2021; 64(2):282-287. PubMed ID: 33851621
[TBL] [Abstract][Full Text] [Related]
19. A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits.
Zhang F; Gao E; Liang S; Yang N; Wang J
Ann Clin Lab Sci; 2018 Jul; 48(4):528-533. PubMed ID: 30143498
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-associated proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
Liu MY; Wang SX; Dong Y; Zhou FD; Zhao MH
J Nephrol; 2021 Oct; 34(5):1669-1672. PubMed ID: 33428097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
